deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02949791

HIPEC Using High Intra-abdominal Pressure (HIPEC-IAP)

Effects of High Intra-abdominal Pressure on Tissue Diffusion and Pharmacokinetics of Cisplatin During HIPEC

Sponsor: Associazione Italiana per la Ricerca sul Cancro

Updated 7 times since 2017 Last updated: Feb 21, 2018 Started: Dec 31, 2014 Primary completion: Nov 30, 2017 Completion: Nov 30, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02949791, this PHASE2 trial focuses on Colorectal Cancer and Pseudomyxoma Peritonei and remains completed. Sponsored by Associazione Italiana per la Ricerca sul Cancro, it has been updated 7 times since 2014, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Mar 2018 · 14 months · monthly snapshotRecruiting~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 11 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

Show 2 earlier versions
  1. Mar 2018 — Jun 2018 [monthly]

    Completed PHASE2

    Status: RecruitingCompleted

  2. Jan 2017 — Mar 2018 [monthly]

    Recruiting PHASE2

    First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Associazione Italiana per la Ricerca sul Cancro
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Data source: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations